ICRM
XYL icon

Insight Capital Research & Management’s Xylem XYL Stock Holding History

Insight Capital Research & Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,083
Closed -$337K – 140
2017
Q2 		$337K Buy
+6,083
New +$317K 0.2% 95

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
IAMU
Impax Asset Management (UK) London, United Kingdom $4.12B AUM 10.79% 1-Year Est. Return

Insight Capital Research & Management's XYL Position: Q3 2017 in Review

Insight Capital Research & Management sold out of Xylem (XYL) in Q3 2017, closing a stake of 6,083 shares — an estimated $337K sold.

Insight Capital Research & Management first reported a position in XYL in Q2 2017 and held it in 1 quarter. The position peaked at $337K in Q2 2017. 573 funds tracked by Wall St. Rank hold XYL as of Q3 2017.

  • Insight Capital Research & Management reported no remaining Xylem position as of Q3 2017 after selling out during the quarter.
  • Insight Capital Research & Management sold 6,083 Xylem shares in Q3 2017, an estimated $337K.
  • Insight Capital Research & Management first reported a position in Xylem in Q2 2017 and held it in 1 quarter.
  • Insight Capital Research & Management's Xylem position peaked at $337K in Q2 2017.
  • 573 funds tracked by Wall St. Rank held Xylem as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.